Immediate Impact
2 from Science/Nature 66 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
2025 Standout
Works of Denis Weber being referenced
Abstract S4-07: BELLE-3: A phase III study of buparlisib + fulvestrant in postmenopausal women with HR+, HER2–, aromatase inhibitor-treated, locally advanced or metastatic breast cancer, who progressed on or after mTOR inhibitor-based treatment
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Denis Weber | 38 | 19 | 34 | 5 | 50 | |
| Dimitar Kalev | 32 | 17 | 33 | 3 | 47 | |
| Juan Ignacio Delgado Mingorance | 27 | 10 | 26 | 6 | 39 | |
| Murray Brunt | 34 | 25 | 46 | 7 | 65 | |
| Andrew W. Navia | 19 | 45 | 37 | 5 | 187 | |
| Nitin Rohatgi | 14 | 19 | 27 | 7 | 58 | |
| Qilong Zhang | 29 | 10 | 41 | 8 | 50 | |
| Filomena Di Giacomo | 33 | 45 | 28 | 4 | 66 | |
| Matthew Lastrapes | 29 | 38 | 27 | 4 | 63 | |
| Kenneth Eng | 24 | 26 | 15 | 5 | 73 | |
| Corinne Lamour | 71 | 10 | 26 | 6 | 164 |
All Works
Loading papers...